Feedback / Questions
EBC-129 - A*Star, National Cancer Centre Singapore
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05701527
Jan 27, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next